- ►diabetesjournals.org M Korytkowski, A Thomas, L Reid, MB … - Diabetes Care, 2002 - Am Diabetes Assoc RESULTS—Glimepiride resulted in a 2.4-mmol/l decrease in fasting plasma
glucose (P = 0.04) that was correlated with reductions in postabsorptive
endogenous glucose production (EGP) (16.4 ± 0.6 vs. 13.5 ± 0.5 μmol · ... Cited by 44 - Related articles - BL Direct - All 5 versions
MU Kabadi, UM Kabadi - Clinical therapeutics, 2004 - Elsevier Methods: This 24-week, open-label, controlled trial was conducted at the
Division of Endocrinology and Metabolism, Veterans Affairs Medical Center
(Phoenix, Arizona). Study participants were aged 32 to 75 years and had ... Cited by 14 - Related articles - All 3 versions
- ►diabetesjournals.org D Overkamp, A Volk, E Maerker, PE Heide, HG … - Diabetes care, 2002 - Am Diabetes Assoc RESEARCH DESIGN AND METHODS—Ten healthy, glucose-tolerant but
insulin-resistant probands were subjected to a placebo-controlled, double-blind,
cross-over study. Each individual received infusions of either 0.15 mol/l ... Cited by 13 - Related articles - BL Direct - All 6 versions
DS Schade, L Jovanovic, J Schneider - The Journal of Clinical Pharmacology, 1998 - jclinpharm.highwire.org On behalf of: American College of Clinical Pharmacology ... David S. Schade,
MD, Lois Jovanovic, MD, and Jill Schneider, MD ... This multicenter,
randomized, placebo-controlled study of ... 300 mg/dL) during a 1-week ... Cited by 43 - Related articles - BL Direct - All 6 versions
MS Rendell, NB Glazer, Z Ye - Journal of diabetes and its complications, 2003 - Elsevier Two separate randomized double-blind trials have reported on the efficacy and
safety of pioglitazone in combination with a sulfonylurea or metformin (Einhorn
et al., 2000 and Kipnes et al., 2001). In one study (Einhorn et al., 2000), ... Cited by 31 - Related articles - All 12 versions
R Weitgasser, M Lechleitner, A Luger, A … - Diabetes research and clinical practice, 2003 - Elsevier Sulphonylureas are effective and well tolerated in patients with Type 2
diabetes, but may be associated with weight gain, and lack of compliance due to
multiple daily dosing. This open, uncontrolled surveillance study examined ... Cited by 21 - Related articles - All 7 versions
[CITATION] Increased prandial insulin secretion following a single preprandial oral dose of repaglinide …
F Gregorio, F Ambrosi, S Cristallini, P … - Acta Diabetologica, 1996 - Springer Abstract The effects of glimepiride, the newest sulpho- nylureic compound, on
pancreatic insulin and glucagon se- cretion were studied using the classical,
isolated, perfused rat pancreas model. The influence of four different ... Cited by 24 - Related articles - BL Direct - All 4 versions
[CITATION] Role of free acids on cardiac autonomic nervous systemic in non insulin-dependent diabetic …
GE Sonnenberg, DC Garg, DJ Weidler, RM … - The Annals of pharmacotherapy, 1997 - Harvey Whitney Books OBJECTIVE: To investigate the metabolic effects and frequency of adverse events
with 6 mg of glimepiride, a new oral sulfonylurea, given both in once- and
twice-daily dosages to patients with non-insulin-dependent diabetes ... Cited by 42 - Related articles - All 3 versions
